Kohunai I, Mori T, Yayoi E, Kosaki G
Nihon Geka Gakkai Zasshi. 1984 Nov;85(11):1387-92.
This study was performed intending to demonstrate whether delayed hypersensitivity (DH) to OK-432 might augment the antitumor effect of intratumoral injection of OK-432. In this preliminary report, we showed that 1) DH to OK-432 was inducible in BALB/c mice by injecting 2KE of OK-432 with Freund's incomplete adjuvant into foot pads 2) DH was assayed by direct macrophage migration inhibition test (MIT) of Harrington's microdroplet method using 100 micrograms/ml of Su-M protein extracted from OK-432 as in vitro test antigen 3) the highest MI was observed in the second week after sensitization 4) strong and stable DH was induced after the second sensitization at the interval of two weeks.
本研究旨在证明对溶链菌制剂(OK-432)的迟发型超敏反应(DH)是否会增强瘤内注射OK-432的抗肿瘤效果。在本初步报告中,我们表明:1)通过将2KE的OK-432与弗氏不完全佐剂注射到BALB/c小鼠的足垫中,可诱导对OK-432的DH;2)使用从OK-432中提取的100微克/毫升的苏-M蛋白作为体外试验抗原,通过哈林顿微滴法的直接巨噬细胞迁移抑制试验(MIT)测定DH;3)在致敏后第二周观察到最高的迁移抑制率(MI);4)在两周的间隔进行第二次致敏后,诱导出强烈且稳定的DH。